A pneumonia outbreak associated with a new coronavirus of probable bat origin.

Peng Zhou, Xing-Lou Yang, Xian-Guang Wang, Ben Hu, Lei Zhang, Wei Zhang, Hao-Rui Si, Yan Zhu, Bei Li, Chao-Lin Huang, Hui-Dong Chen, Jing Chen, Yun Luo, Hua Guo, Ren-Di Jiang, Mei-Qin Liu, Ying Chen, Xu-Rui Shen, Xi Wang, Xiao-Shuang Zheng, Kai Zhao, Quan-Jiao Chen, Fei Deng, Lin-Lin Liu, Bing Yan, Fa-Xian Zhan, Yan-Yi Wang, Geng-Fu Xiao, Zheng-Li Shi
Author Information
  1. Peng Zhou: CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  2. Xing-Lou Yang: CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  3. Xian-Guang Wang: Wuhan Jin Yin-Tan Hospital, Wuhan, China.
  4. Ben Hu: CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  5. Lei Zhang: CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  6. Wei Zhang: CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  7. Hao-Rui Si: CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  8. Yan Zhu: CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  9. Bei Li: CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  10. Chao-Lin Huang: Wuhan Jin Yin-Tan Hospital, Wuhan, China.
  11. Hui-Dong Chen: Wuhan Jin Yin-Tan Hospital, Wuhan, China.
  12. Jing Chen: CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  13. Yun Luo: CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  14. Hua Guo: CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  15. Ren-Di Jiang: CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  16. Mei-Qin Liu: CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  17. Ying Chen: CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  18. Xu-Rui Shen: CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  19. Xi Wang: CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  20. Xiao-Shuang Zheng: CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  21. Kai Zhao: CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  22. Quan-Jiao Chen: CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  23. Fei Deng: CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  24. Lin-Lin Liu: Hubei Provincial Center for Disease Control and Prevention, Wuhan, China.
  25. Bing Yan: CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  26. Fa-Xian Zhan: Hubei Provincial Center for Disease Control and Prevention, Wuhan, China.
  27. Yan-Yi Wang: CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  28. Geng-Fu Xiao: CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  29. Zheng-Li Shi: CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China. zlshi@wh.iov.cn.

Abstract

Since the outbreak of severe acute respiratory syndrome (SARS) 18 years ago, a large number of SARS-related coronaviruses (SARSr-CoVs) have been discovered in their natural reservoir host, bats. Previous studies have shown that some bat SARSr-CoVs have the potential to infect humans. Here we report the identification and characterization of a new coronavirus (2019-nCoV), which caused an epidemic of acute respiratory syndrome in humans in Wuhan, China. The epidemic, which started on 12 December 2019, had caused 2,794 laboratory-confirmed infections including 80 deaths by 26 January 2020. Full-length genome sequences were obtained from five patients at an early stage of the outbreak. The sequences are almost identical and share 79.6% sequence identity to SARS-CoV. Furthermore, we show that 2019-nCoV is 96% identical at the whole-genome level to a bat coronavirus. Pairwise protein sequence analysis of seven conserved non-structural proteins domains show that this virus belongs to the species of SARSr-CoV. In addition, 2019-nCoV virus isolated from the bronchoalveolar lavage fluid of a critically ill patient could be neutralized by sera from several patients. Notably, we confirmed that 2019-nCoV uses the same cell entry receptor-angiotensin converting enzyme II (ACE2)-as SARS-CoV.

References

Emerg Infect Dis. 2013 Jun;19(6):989-91 [PMID: 23739658]
Nature. 2013 Nov 28;503(7477):535-8 [PMID: 24172901]
N Engl J Med. 2003 May 15;348(20):1967-76 [PMID: 12690091]
Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):3048-53 [PMID: 26976607]
Viruses. 2019 Mar 02;11(3): [PMID: 30832341]
Nat Rev Microbiol. 2019 Mar;17(3):181-192 [PMID: 30531947]
Science. 2005 Oct 28;310(5748):676-9 [PMID: 16195424]
N Engl J Med. 2012 Nov 8;367(19):1814-20 [PMID: 23075143]
Nature. 2003 Nov 27;426(6965):450-4 [PMID: 14647384]
PLoS Pathog. 2017 Nov 30;13(11):e1006698 [PMID: 29190287]
Virol Sin. 2018 Feb;33(1):104-107 [PMID: 29500691]
J Virol. 2005 Feb;79(4):2001-9 [PMID: 15681402]
Nat Med. 2015 Dec;21(12):1508-13 [PMID: 26552008]

MeSH Term

Angiotensin-Converting Enzyme 2
Animals
Antibodies, Viral
Betacoronavirus
COVID-19
Cell Line
China
Chiroptera
Chlorocebus aethiops
Coronavirus Infections
Disease Outbreaks
Female
Genome, Viral
Humans
Male
Peptidyl-Dipeptidase A
Phylogeny
Pneumonia, Viral
Severe acute respiratory syndrome-related coronavirus
SARS-CoV-2
Sequence Homology, Nucleic Acid
Severe Acute Respiratory Syndrome
Vero Cells

Chemicals

Antibodies, Viral
Peptidyl-Dipeptidase A
ACE2 protein, human
Angiotensin-Converting Enzyme 2